Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan.
Surgery
; 115(1): 39-45, 1994 Jan.
Article
in En
| MEDLINE
| ID: mdl-8284759
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Chemotherapy, Cancer, Regional Perfusion
/
Extremities
/
Melanoma
/
Melphalan
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Surgery
Year:
1994
Document type:
Article
Country of publication:
Estados Unidos